Global Pharyngitis Treatment Market: Industry Analysis and Forecast 2020 -2026: By Source of Infection, Drug Class, Distribution Channel and Region.

Global Pharyngitis Treatment Market is anticipated to reach US$ 1,679.1 Mn by 2026 from US$ XX Mn in 2019 at a CAGR of XX% during a forecast period.

Global Pharyngitis Treatment Market Overview

Pharyngitis is a condition that causes inflammation of the pharynx. It is most usually referred to as a painful throat. It produces pain, irritation, and scratchiness in the throat, making swallowing difficult. The most prevalent cause of pharyngitis is viral infections such as the common cold, influenza, and others. Early therapy is required to alleviate discomfort. Sneezing, runny nose, headache, weariness, body pains, chills, and other symptoms are usually connected with the illnesses. Global Pharyngitis Treatment Market To know about the Research Methodology :- Request Free Sample Report

Global Pharyngitis Treatment Market Dynamics

The high prevalence and rising incidence of flu are expected to boost the global pharyngitis treatment market. The American Osteopathic Association (AOA) reports that pharyngitis-induced sore throat is one of the major causes of physician visits in the United States. Some of the most frequent causes of sore throat include viral infections such as the common cold, influenza, and mononucleosis. According to the World Health Organization, around 3-5 million instances of severe flu are registered worldwide each year, with between 2,500 and 3,000 fatalities occurring. According to a World Health Organization (WHO) estimate, around 86 percent of the world children population got in 2019. Pharyngitis is caused by a bacterial infection in the pharynx (the back of the throat). This results in throat swelling and soreness, trouble swallowing and speaking, and fever. The rising need for therapy to alleviate these symptoms is also expected to drive market growth. Furthermore, according to the Centers for Medicare & Medicaid Services (CMS), the expected average annual percent change in National Health Expenditures (NHE) in the United States was 5.2 % in 2020 compared to 2019. Furthermore, National Health Expenditures are expected to reach USD 6,192.5 billion in 2026, with per capita spending reaching USD 17,611 in the same year. These are significant signs that are expected to generate significant revenue prospects during the forecast period. Global Pharyngitis Treatment Market

Global Pharyngitis Treatment Market Segmentation Analysis

By Source of Infection, the global pharyngitis therapy market is divided into viral and bacterial segments. By the end of 2026, the viral source is expected to account for a significant portion of the global pharyngitis treatment market. Global Pharyngitis Treatment Market By Drug Class, beta lactams are expected to be one of the most desired between 2019 and 2026. Beta lactams are expected to generate over $500 million in sales by the end of 2026. Cephalosporins and penicillins are examples of beta-lactam antibiotics. These drugs are effective against a wide range of dangerous germs. Furthermore, the recent introduction of broad-spectrum beta-lactam antibiotics active against gram-negative bacteria has enhanced their use. By Distribution Channel, Retail pharmacies and drug stores are expected to obtain the greatest revenue share. Retail pharmacies and drug stores are expected to generate over US$ 700 million in sales by the end of 2026. A sore throat is fairly frequent. Pharmacists can examine particular symptoms stated by patients and provide Over-the-Counter (OTC) drugs available at retail pharmacies and drug shops depending on their findings. Lozenges are one of the most often used over-the-counter medications for treating a sore throat. Furthermore, pharmaceutical firms are launching new medications that can provide immediate pain relief.

Global Pharyngitis Treatment Market Regional Analysis

The market in North America is expected to account for the greatest share throughout the projected period due to high healthcare spending, rising health awareness among people, and increased investment in R&D activities. According to another WHO estimate, North America's per capita healthcare spending in 2018 was USD 10,050.279. Furthermore, the existence of large pharmaceutical firms, as well as significant expenditure in vaccine research and distribution, is expected to drive market growth. The Asia Pacific area is expected to have the greatest CAGR throughout the forecast period, owing to a high incidence of pharyngitis, a large population, and an increased risk of infection. Furthermore, the growing public healthcare system in countries such as India and China is expected to drive market growth. Global Pharyngitis Treatment MarketThe objective of the report is to present a comprehensive analysis of the Global Pharyngitis Treatment Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Pharyngitis Treatment Market dynamics, structure by analyzing the market segments and project the Global Pharyngitis Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pharyngitis Treatment Market make the report investor’s guide.

Global Pharyngitis Treatment Market Scope: Inquire before buying

Global Pharyngitis Treatment Market

Global Pharyngitis Treatment Market by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Global Pharyngitis Treatment Market Key Players

• Genentech Inc • Adamas Pharmaceutical Inc • PLIVA HRVATSKA d.o.o • Pfizer Inc • Valeant Pharmaceuticals International, Inc • Mylan N.V • GSK group of companies • Teva Pharmaceutical Industries Ltd • AbbVie Inc • Viatris Inc. (Mylan) • GlaxoSmithKline plc • Abbott Laboratories • AbbVie Inc • Amgen Inc • Sanofi-aventis Groupe • Purdue Pharma L.P
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pharyngitis Treatment Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pharyngitis Treatment Market 3.4. Geographical Snapshot of the Pharyngitis Treatment Market, By Manufacturer share 4. Global Pharyngitis Treatment Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Pharyngitis Treatment Market 5. Supply Side and Demand Side Indicators 6. Global Pharyngitis Treatment Market Analysis and Forecast, 2019-2026 6.1. Global Pharyngitis Treatment Market Size & Y-o-Y Growth Analysis. 7. Global Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 7.1.1. Viral 7.1.2. Bacterial 7.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 7.2.1. Beta Lactams 7.2.2. Macrolides 7.2.3. Cephalosporins 7.2.4. Fluoroquinolones 7.2.5. Tetracycline 7.2.6. Other Products 7.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.3.1. Hospital Pharmacies 7.3.2. Retail Pharmacies and Drug Stores 7.3.3. Online Pharmacies 8. Global Pharyngitis Treatment Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 9.1.1. Viral 9.1.2. Bacterial 9.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 9.2.1. Beta Lactams 9.2.2. Macrolides 9.2.3. Cephalosporins 9.2.4. Fluoroquinolones 9.2.5. Tetracycline 9.2.6. Other Products 9.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 9.3.1. Hospital Pharmacies 9.3.2. Retail Pharmacies and Drug Stores 9.3.3. Online Pharmacies 10. North America Pharyngitis Treatment Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 12. Canada Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 13. Mexico Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 14. Europe Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 15. Europe Pharyngitis Treatment Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 17. France Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 18. Germany Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 19. Italy Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 20. Spain Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 21. Sweden Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 22. CIS Countries Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 23. Rest of Europe Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 24. Asia Pacific Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 25. Asia Pacific Pharyngitis Treatment Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 27. India Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 28. Japan Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 29. South Korea Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 30. Australia Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 31. ASEAN Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 32. Rest of Asia Pacific Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 33. Middle East Africa Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 34. Middle East Africa Pharyngitis Treatment Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 36. GCC Countries Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 37. Egypt Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 38. Nigeria Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 39. Rest of ME&A Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 40. South America Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 41. South America Pharyngitis Treatment Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 43. Argentina Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 44. Rest of South America Pharyngitis Treatment Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Source of Infection, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Distribution Channel , 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Pharyngitis Treatment Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Pfizer Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.4. Genentech Inc 45.5. Adamas Pharmaceutical Inc 45.6. PLIVA HRVATSKA d.o.o 45.7. Pfizer Inc 45.8. Valeant Pharmaceuticals International, Inc 45.9. Mylan N.V 45.10. GSK group of companies 45.11. Teva Pharmaceutical Industries Ltd 45.12. AbbVie Inc 45.13. Viatris Inc. (Mylan) 45.14. GlaxoSmithKline plc 45.15. Abbott Laboratories 45.16. AbbVie Inc 45.17. Amgen Inc 45.18. Sanofi-aventis Groupe 45.19. Purdue Pharma L.P 1. Primary Key Insights

About This Report

Report ID106231
Category Healthcare
Published DateJun 2021
Updated Date
Contact Us